Dianthus Therapeutics, Inc.
← Back to DNTH Overview

Dianthus Therapeutics, Inc. (DNTH)

Solvency & Capital Structure

Total Debt

$1.4M

Net Debt

-$1.11B

Dianthus Therapeutics, Inc. currently has $1.4M in total debt. Net debt is -$1.11B after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

DNTHQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.001.11-1.11Net Cash1.250.1%
2025-12-310.000.40-0.40Net Cash0.530.3%
2025-09-300.000.40-0.40Net Cash0.580.2%
2025-06-300.000.26-0.26Net Cash0.330.4%
2025-03-310.000.26-0.26Net Cash0.350.4%
2024-12-310.000.28-0.27Net Cash0.370.4%
2024-09-300.000.28-0.28Net Cash0.350.1%
2024-06-300.000.36-0.36Net Cash0.370.1%
2024-03-310.000.38-0.38Net Cash0.380.1%
2023-12-310.000.17-0.17Net Cash0.180.3%
2023-09-300.000.19-0.19Net Cash0.190.3%
2023-06-300.000.08-0.08Net Cash0.080.0%
2023-03-310.000.08-0.08Net Cash0.080.0%
2022-12-310.000.08-0.07Net Cash0.080.9%
2022-09-300.030.13-0.10Net Cash0.1618.8%
2022-06-300.030.14-0.11Net Cash0.1818.1%
2022-03-310.030.16-0.12Net Cash0.1916.6%
2021-12-310.000.18-0.18Net Cash0.190.0%
2021-09-300.000.19-0.19Net Cash0.210.0%
2021-06-300.000.21-0.21Net Cash0.220.0%
2021-03-310.000.13-0.13Net Cash0.140.0%
2020-12-310.000.15-0.15Net Cash0.160.0%
2020-09-300.000.16-0.16Net Cash0.170.0%
2020-06-300.000.18-0.18Net Cash0.190.0%
2020-03-310.000.13-0.13Net Cash0.140.0%
2019-12-310.000.15-0.15Net Cash0.160.0%
2019-09-300.000.16-0.16Net Cash0.180.0%
2019-06-300.000.17-0.17Net Cash0.200.0%
2019-03-310.000.13-0.13Net Cash0.150.0%
2018-12-310.000.14-0.14Net Cash0.160.0%
2018-09-300.000.16-0.16Net Cash0.170.0%
2018-06-300.000.17-0.17Net Cash0.180.0%
2018-03-310.000.04-0.04Net Cash0.050.0%
2017-12-310.000.05-0.05Net Cash0.050.0%